10/31/2024 | Press release | Distributed by Public on 10/31/2024 10:19
Binghamton School of Pharmacy and Pharmaceutical Sciences Professor Sarah Spinler has been honored with the 2024 Clinical Practice Award from the American College of Clinical Pharmacy (ACCP). The career achievement award is given to someone who has dedicated their life to helping others and who is making an outstanding contribution to clinical pharmacy practice.
"Receiving recognition for something I love, clinical practice impacting patient care, from the organization with the word 'clinical' in it, is such an honor," said Spinler, a professor of pharmacy practice.
To be considered for the award, the ACCP has laid out criteria that a candidate and their contribution must meet.
An outstanding contribution is judged by:
The contribution(s) must be judged outstanding by their impact on clinical pharmacy practice and/or by a substantial impact on the care of a sizable number of patients.
Binghamton Professor Sarah Spinler giving her acceptance speech for the 2024 Clinical Practice Award at the ACCP Annual Meeting. Image Credit: ACCP.Spinler said receiving the award would not have been possible without those who guided her throughout her career. Now, she is carrying on their legacy by teaching the next generation of pharmacists at Binghamton.
"In my acceptance speech, I mentioned the teachers and practice experiences I had in my PharmD program at the University of Minnesota from outstanding pharmacist clinicians who inspired me to a life's work of teaching pharmacy students, pharmacists, residents and cardiologists about using drug therapy to optimize patient outcomes," she said. "Seeing those individuals go on to teach others is my reward."
In her letter of support, Jean Nappi, professor emeritus at Medical University of South Carolina College of Pharmacy, commented on how Spinler's research has affected health care outside pharmacy practice.
"Dr. Spinler is nationally recognized outside of pharmacy for her expertise, having served on numerous committees, writing groups and panels that addressed important practice issues in the American Heart Association, American College of Cardiology, Agency for Healthcare Research and Quality and the United States Pharmacopeia," said Nappi "For example, she contributed to the 'Patients at Risk for Developing Left Ventricular Thrombus' Guideline Writing Panel of the American Heart Association and the 'Expert Consensus Decision Pathway Writing Group for Bridging Anticoagulants' of the American College of Cardiology. Her dedication to the profession of pharmacy, and as a representative of the profession of pharmacy to medical groups, has helped raise the level of clinical pharmacy practice."
Spinler has focused her career on direct patient care, taking a hands-on approach to help those who need it.
"My contributions to direct patient care were primarily performed as a faculty member at Philadelphia College of Pharmacy, where my practice site was the Hospital of the University of Pennsylvania," she said. "However, other contributions to the care of patients with cardiovascular diseases were also recognized, including those that I continue to make while in my faculty role here at Binghamton, including serving on national guideline-writing panels with both the American Heart Association and the American College of Cardiology."
Spinler also was recognized for her contributions to a research poster that was presented at the 2024 ACCP Annual Meeting. Along with fourth-year pharmacy student Jacob Govel and Binghamton Clinical Associate Professor Wes Kufel, she presented their conclusions on "Board Certification Exposure and Awareness Among Doctor of Pharmacy Programs."